1209069004: Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Phosphotransferase inhibitor-containing product\Protein kinase inhibitor-containing product\Epidermal growth factor receptor antagonist antineoplastic agent\Trastuzumab emtansine-containing product\Trastuzumab emtansine-containing product in parenteral dose form\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Phosphotransferase inhibitor-containing product\Protein kinase inhibitor-containing product\Epidermal growth factor receptor antagonist antineoplastic agent\Trastuzumab emtansine-containing product\Trastuzumab emtansine only product\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Trastuzumab emtansine-containing product\Trastuzumab emtansine-containing product in parenteral dose form\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Trastuzumab emtansine-containing product\Trastuzumab emtansine only product\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Antibody-containing product\Monoclonal antibody-containing product\Monoclonal antibody antineoplastic agent\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Trastuzumab emtansine only product\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorised by therapeutic role\Antineoplastic agent\...
• \Monoclonal antibody antineoplastic agent\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Trastuzumab emtansine only product\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Epidermal growth factor receptor antagonist antineoplastic agent\Trastuzumab emtansine-containing product\...
• \Trastuzumab emtansine-containing product in parenteral dose form\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Trastuzumab emtansine only product\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial
• \Product manufactured as parenteral dose form\Trastuzumab emtansine-containing product in parenteral dose form\Trastuzumab emtansine only product in parenteral dose form\Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial

Status: current, Defined. Date: 31-May 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5014317010	Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial	en	Synonym	Active	Case insensitive	SNOMED CT core
5014318017	Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core

Expanded Value Set

Reference Sets

Australian dialect reference set

Back to Start